Syncromune Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Syncromune Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Syncromune Inc Today - Breaking & Trending Today

Syncromune® Inc. Expands Scientific Advisory Board with Addition of Prominent Oncology Trailblazer James Armitage, M.D.

Published: October 31, 2023

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Oct 31, 2023--

Source: eagletribune.com

Related Topics:

France GeneralHaute NormandieUnited StatesSan SalvatoreSwitzerland GeneralEamonn HobbsRoberta KyleJames ArmitageDanielle HobbsRoyal College Of PhysiciansAssociation Of American PhysiciansAmerican Society For TransplantationAmerican Society Of Clinical OncologyCorporate CommunicationsHinda Rosenthal Foundation Research AwardSyncromune IncExchange CommissionDivision Of Oncology HematologyDepartment Of MedicineAmerican Association For Advancement Of SciencesDean Of The College MedicineSan Salvatore Foundation Research AwardUniversity Of Texas Md Anderson Cancer CenterAmerican Association Of Cancer ResearchAmerican College Of Physicians

Syncromune® Inc., Appoints Jonathan Lewis, M.D., Ph.D., A Renowned Immune Therapy Pioneer, as Chief Medical Officer

Published: July 12, 2023

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Jul 12, 2023--

Source: valdostadailytimes.com

Related Topics:

United StatesUnited KingdomMemorial Sloan Kettering Cancer CenterNew YorkCity OfSouth AfricaKristen Ann CarrDanielle HobbsEamonn HobbsJonathan LewisAntigenics IncNone Of Syncromune IncZiopharm OncologySyncromune IncInvestor Relations Corporate CommunicationsYale UniversityRoyal College Of Surgeons Trubshaw MedalExchange CommissionRoyal College Of SurgeonsDivision Of Hematologic OncologyCambridge UniversityYale University Ohse FellowshipUniversity Of Cambridge Churchill FellowshipClinical Immunology ServiceWitwatersrand University

3SBio announces 2022 annual results, with revenue rising 7.5% year on year and normalized net profit attributable to parents jumping 25.2%

Published: March 22, 2023

/PRNewswire/ -- Chinese leading biopharmaceutical company 3SBio (01530.HK) today announced its 2022 annual results. In 2022, 3SBio's core biopharmaceutical...

Source: prnewswire.com

Related Topics:

United StatesNational Engineering Research CenterCosmo Pharmaceuticals3sbio IncChengdu Kelingyuan Pharmaceutical Technology Co LtdNational Reimbursement Drug ListSyncromune IncChinese Society Of Clinical OncologyChinese SocietyClinical OncologyClinical GuidelinesCancer Therapy Induced ThrombocytopeniaBreast CancerAndrogenetic AlopeciaChinese PopulationChinese Expert ConsensusAntibody MedicineCherish Life